The assessment and maintenance of perioperative blood volume is important because fluid therapy is a routine part of intraoperative care. In the past, patients undergoing major surgery were given large amounts of fluids because health-care providers were concerned about preoperative dehydration and intraoperative losses to a third space. In the last decade it has become clear that fluid therapy has to be more individualized. Because the exact determination of blood volume is not clinically possible at every timepoint, there have been different approaches to assess fluid requirements, such as goal-directed protocols guided by invasive and less invasive devices. This article focuses on laboratory volume determination, capillary dynamics, aspects of different fluids and how to clinically assess and monitor perioperative blood volume.
Previously, a mini volume loading test (mVLT) detected signs of dehydration in healthy volunteers after an overnight fast. Our objective was to investigate whether mVLT could indicate preoperative dehydration in patients after an overnight fast. The mVLT was performed in 36 elective primary total knee arthroplasty patients. Each subject received three fluid challenges before anesthesia induction. These consisted of 5 mL/kg boluses of Ringer's acetate infused over 3-5 min and followed by a 5-min period without fluids. Invasive (arterial, venous) and noninvasive (capillary) measurements of hemoglobin concentration were performed before and after each fluid challenge, as well as after a 20-min period without fluids which followed the last bolus. Arterial, venous and capillary plasma dilutions were calculated in every data point. Dilution values were used to calculate the plasma dilution efficacy of each fluid challenge. Venous dilution was higher than capillary after the first fluid challenge (P=0.030), but lower than capillary after 20 min period following the last bolus (P=0.009). Arterial dilution was lower than capillary (P=0.005) after 20 min following the last bolus. Veno-capillary and arterio-capillary plasma dilution efficacy differences decreased (P=0.004 and P=0.033, respectively) from positive to negative during mVLT. These are signs of re-hydration from pre-existing dehydration according to a transcapillary reflux model. Signs of dehydration were observed during mVLT in patients after pre-operative overnight fast. A revised transcapillary reflux model was proposed to explain the results.
A mini volume loading test (mVLT) was proposed for estimating hydration status and interstitial fluid accumulation during stepwise infusion of crystalloids. The method is based on both the transcapillary reflux model and the hypothesis that when subjects are dehydrated, venous plasma dilution induced by a fluid challenge is higher than in the capillaries, and that difference is diminished when the fluid challenge is given to more hydrated individuals. Our objective was to test that hypothesis by evaluating the veno-capillary dilution difference during mVLT in subjects with different hydration status. In a prospective randomized crossover study, three mini fluid challenges were given to 12 healthy volunteers on two occasions. The subjects were either dehydrated or hydrated before the experiments. In dehydrated subjects only, capillary plasma dilution was significantly lower than venous (P=0.015, 0.005 and 0.006) after each mini fluid challenge. Veno-capillary dilution difference during mVLT depends on the hydration status. The mVLT method could possibly discriminate between the different states of hydration.
19 November 2014 in Elektronika ir Elektrotechnika
Goal directed fluid therapy (GDFT) implies the flow-related parameters guided infusion of fluids. It requires adherence to complex clinical algorithms and fluid protocols, as well as simultaneous monitoring of several parameters and evaluation of their fluid responsiveness or actual response to fluid challenges. Automated clinical decision support systems (ACDSS) are used to ease the task. However, they are based on the flow-related (hemodynamic) parameters – arterial blood pressure, cardiac output, etc. Meanwhile, infusions guided by hemodynamic endpoints may lead to edema. A mini Volume Loading Test (mVLT) may be helpful in detection of imminent edema from changes in hemodilution during stepwise infusion which is conventionally used for hemodynamic optimization. We developed an ACDSS which is based on evaluation of both hemodynamic and hemodilution parameters. It operates on the basis of our unique algorithm which implies interchangeable application of fluid loading, vasopressor injection and red cell transfusion. This ACDSS is used in our PC-based command centre of a prototype semi-closed loop (SCL) infusion system. We developed a simulator – ‘Virtual Patient’ – on the basis of our previous clinical records aiming to test a new controller, as well as train the research team before starting a clinical trial. In silico testing continued for 12 hours on five occasions. Primary endpoint was the compliance of a controller with our clinical algorithm and the stability of operation in a spectrum of arterial hypotension and bleeding scenarios. The prototype SCL infusion system was found ready for clinical validation. DOI: http://dx.doi.org/10.5755/j01.eee.20.9.8520
11 February 2015 in Elektronika ir Elektrotechnika
An In Silico testing of our novel automated clinical decision support system (ACDSS) in a prototype semi-closed loop (SCL) infusion system was previously reported. The decision making therein is based on the evaluation of hemodynamic and hemodilution parameters in compliance with an algorithm that implies interchangeable application of fluid infusion, vasopressor injection and red cell transfusion. Before starting the clinical validation trial, several amendments to the clinical algorithm were made on the basis of minor deficiencies revealed during an In Silico testing. For an intervention group in an on-going prospective randomised clinical trial, our prototype SCL infusion system is applied continuously for 12 perioperative hours in patients undergoing total hip replacement. This report describes our preliminary observations of the system’s performance in first 12 patients from an intervention group who completed the study.DOI: http://dx.doi.org/10.5755/j01.eee.21.1.2458